Zydus Cadila's MD is new IPA president
This article was originally published in Scrip
Pankaj R Patel, chairman and managing director of Zydus Cadila, has taken over as president of the Indian Pharmaceutical Alliance (IPA), which represents leading domestic companies. Mr Patel, previously vice-president of the IPA, succeeds Sudhir Mehta, chairman of the Torrent group. Dr Prakash A Mody, chairman and managing director of Unichem Laboratories, takes over as vice-president. Formed with eight members in November 1999, the IPA now has 12 Indian member companies that account for more than one-third of the country’s pharmaceutical exports.
You may also be interested in...
Wockhardt has received approvals in India for two novel broad spectrum antibiotics with "advantageous" safety features over older MRSA drugs and the firm hopes to take them to other emerging markets as well, with China on the radar.
2019 saw Indian companies advance innovation efforts and build and expand their specialty portfolios and biosimilars businesses. But manufacturing compliance issues weighed down several firms while on another front charges against the Singh brothers of Ranbaxy escalated.
Glenmark is working on a combination of remogliflozin and teneligliptin in India, which if successful could bring additional sting to its portfolio in the country's bustling diabetes segment. But Boehringer-Lilly’s rival Glyxambi already has a head-start.